Journal profile · GASTROENTEROLOGY & HEPATOLOGY
Gastrointestinal Tumors
ISSN 2296-3774 · eISSN 2296-3766 · Karger Publishers · Switzerland
Gastrointestinal Tumors: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 990; review about 17 weeks (community reports); 19 articles in 2025; indexed in ESCI; the journal's website says it has moved to a new publisher.
The journal's website says it has moved to a new publisher: Gastrointestinal Tumors is no longer published by Karger Publishers. All articles published in the journal (Volumes 1-10) will continue to be archived and searchable. Source ↗Publisher website ·
Scope
Aims, scope and focus
Gastrointestinal Tumors is published by Karger Publishers and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Hepatocellular Carcinoma Treatment and Prognosis, Gastric Cancer Management and Outcomes and Pancreatic and Hepatic Oncology Research, together about 24.1% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): GASTROENTEROLOGY & HEPATOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Hepatocellular Carcinoma Treatment and PrognosisMedicine9.1%
- Gastric Cancer Management and OutcomesMedicine8.3%
- Pancreatic and Hepatic Oncology ResearchMedicine6.8%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance6.3%
- Esophageal Cancer Research and TreatmentMedicine5.3%
- Gastrointestinal Tumor Research and TreatmentMedicine5.3%
- Human auditory perception and evaluationEngineering5.3%
- Colorectal Cancer Screening and DetectionMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 28OpenAlex ·
- i10-index
- 69OpenAlex ·
- 2-year mean citedness
- 0.45OpenAlex ·
- Self-citation rate
- 9.1%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 19LetPub ·
Articles by year OpenAlex count · 244 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 13 | 13 | 0 |
| 2025 | 19 | 19 | 6 |
| 2024 | 8 | 8 | 12 |
| 2023 | 6 | 6 | 21 |
| 2022 | 5 | 5 | 14 |
| 2021 | 28 | 28 | 136 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 17 weeksLetPub ·
- Peer review
- Blind peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | CHF 920 / EUR 850 / USD 990 | — | — | |
| LetPub | No APC | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Karger Publishers
- Country or region
- Switzerland
- Language
- English
- ISSN
- 2296-3774
- Electronic ISSN
- 2296-3766
- Latest issue on the website
- Volume 10, Issue 1 (December 2023)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Gastrointestinal Tumors
What CAS zone is Gastrointestinal Tumors in?
In the 2025 upgraded edition of the CAS Journal Ranking, Gastrointestinal Tumors is in Zone 4 of Medicine, and in Zone 4 of the minor category Gastroenterology & Hepatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Gastrointestinal Tumors?
Authors report an average review time of about 17 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Gastrointestinal Tumors?
According to LetPub and DOAJ records, Gastrointestinal Tumors is indexed in ESCI and DOAJ.
Is Gastrointestinal Tumors open access, and what is the APC?
Gastrointestinal Tumors is a fully open-access journal. APC about USD 990.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .